poéilim an
`Bioatztive M'ate!fials'_
`June 15-19, 199?
`
`\
`
`netease séiciety, iiic.
`
`-I
`'5»? a *
`,,.;:.;.=;..; _
`_ :4.-IMA-I-;{»2g;;9;o.1¢g.ag¢,m,R!
`V303 K H0 H5 '
`
`‘June is 19.199?
`5‘-iixitilfit: jziié-e l?~ -1.9, 11319?
`S”?€J(?¥{§¥f.P-1&3 2s{.«'i$.‘5A'N
`Staci: imlmi isaternatinnai ‘Fairs
`Wcrkshopst
`him .151 1997
`Slmmu.-.11 -ii-zaie,-I and
`K.‘-«tim:l El-ate}
`_
`jzzr:::..‘;f$_ .199?
`S'¥‘€J{i§E.i{O§.&»iSi-ic‘§SS:Si‘é'
`Siodshtaim ’:'r.ttm_:t;£oz:::! 1“air-<3
`
`'
`
`Program Cfiairs: -
`Km-I.-Erik I-Elk
`Asma
`A33, I?.'.‘aA
`
`RBP_TEVA05024314
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`E
`
`I
`(‘3au:»-_?.v!i*.:t~.a=l 'fi:.'.Imr:i§;r 4:!’ Sa':ttI:m.d, Cirrnrganr
`
`;;.;I
`
`ur
`
`gm. Em
`Mari: Mmhagii.
`Tm,» Mam. .-’LI.aM13.I3§I:oraan‘1e's_._ E:-SA
`
`;R
`
` R
`
`;T
`
`E
`
`iI
`
`RBP_TEVA05024315
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`1996~'._i:=997' Qffi-Ears-at iris: (?o1itri;iieii5 Society, Inc
`View Pttmiént ‘
`‘
`'
`1‘§mmu5:.i£imn:ll
`Pi1Zi_I&111xs;i.54i‘iwr.fi:i:3' uf ifisrburg
`-’*‘5i3*'-**“‘3"r3"’W‘-‘*““-“‘
`“'
`
`TMJHBK Nfifilali
`.‘i«:J>.-’-§1i§‘.vz'|iat:r:1'~.-<13’
`T"“-‘*-"’-~3*P““-
`
`'
`
`3
`
`-
`
`'
`
`Z _
`
`.
`.
`
`_
`
`'
`
`-
`
`_
`
`Pra‘e'a'eicIent-
`
`.:
`
`..
`
`.
`
`".53"!
`mi
`Rummy at liniifin nix
`SsmZ=F:':-.nr:Iagm,flA
`"
`L‘-"SA
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. . .
`
`. , .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`plesaixai
`.
`.
`.
`.
`.
`us Dc‘:iw:'_v TI
`..
`nzrerinargw .£»,[.vp1ir..-xtéounsof
`W .:..:.........................,.......I:-35-35¢}
`mgr.-‘(ante Brag Carrigzrs
`.
`.
`.
`.
`.
`.
`.
`. . .
`.
`.
`.
`.
`.
`.
`.
`.
`
`.
`
`.
`
`. . .
`
`. Jfillfi
`
`.
`
`.
`
`. .15‘:-I-fat’!
`
`.
`
`.
`
`.
`
`.
`
`.
`
`_
`
`. . .
`
`.
`
`.
`
`,
`
`.
`
`.
`
`_ . _
`
`.
`
`.
`
`. Ifii~I??*.
`
`paw. ,,
`1‘;;_§I_f
`361%;
`20:-ms
`"309-215-
`22622.’?
`
`"I-‘.E4«.'?..3Q
`23 3-246
`241-319
`
`250- 236
`
`257-):I'&.I‘
`
`sm-30::
`
`"?II'J9'-3ifi
`
`EH7-321
`
`[Pm fleiixery iii .
`
`.
`
`.
`
`.
`
`.
`Z
`:’
`‘5fi"‘I~"
`!*!wrxo'.Ra :ji+¢!3 :22 mi: 6539
`Elia-,~Z§;Zq.;;.t7i.;-gI::_-,*Z:§Z};.!»s:j;fg:Zur,a;;¢.f.';
`
`.
`
`Z
`
`.
`
`-
`
`Z..
`"'
`
`.
`
`.
`
`'
`
`I
`
`"
`
`'
`.
`
`Z
`Z
`Z
`..
`5&1!"-i*'+‘1‘§'§S€‘
`pang-,¢_ggZ;,,¢,
`Z
`
`.
`
`.
`
`.
`
`Z
`
`Z
`
`.
`
`_
`
`_
`
`ix} ‘I-'§+tx.ri:1ar;' A533?-i:'t‘3£_ii_t'.!:5:2
`N-mi Rtinam:
`'
`'I'.r¢:nIa'.":"J:'>.'e3 Deiizerrgl. . .'.
`.
`Z
`Z
`Z
`Z
`Z
`Z
`Z
`Z
`
`'
`
`-
`
`.
`
`-
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. . .
`
`.
`
`.
`
`.
`
`.
`
`. . .
`
`.
`
`.
`
`.
`
`.:§as:-aszgs,
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`, ..7:!.'*3-7'12
`Z
`Z Z'749_Z,M
`...
`.
`.38!-E€£'§'?.
`.
`...... .....105i5'-I-$35!?
`
`ITJO['f!t"'W>|'-ij
`
`V5142E'!!1*r-iZ~©IC'5.
`
`325?;-3I’5E3
`351-33-i
`
`335--3e!{J
`-#‘0.f-»s*N
`
`dfli-465
`
`.:m..;:4
`stleusssw
`stirszzszsw
`
`is2~:m.52s:9
`Wt}!-(R58?
`mag‘.-W22
`é'ia')f.-r';i£!'.'
`-
`_:.’=2u'}I.-r‘:'£'1i
`:$".‘.(‘.-3-
`‘ii?
`5Z¢,m_,-W-Z_Z-Z
`.
`(‘-‘$33!-5-525?
`
`.
`
`Z
`
`.
`
`RBP_TEVA05024316
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`.P,,,3,:,w gf vaiidafing fi:a,t}ae<<:rmi-aai
`sggszmch. The expexzcd peak ltrcatiizm gm?
`mam c>!xhe=§x1'iz':s. iizstzefiuoszi 1% zmsmm
`fix dwdenum) is_i2ui':~:.at4:d In the fi ms.
`The peak -at the. .561‘-.:s.is: £3-33¢'11§"..1 .
`=:5a.=gm:= the. ‘distances --{If *1’:-2. fmm -mu
`esnxame ta !§'v.°."d1mdbnnm,reBo-:tin the
`fat; the: rm boius was hwdmfi. I
`95“
`31:19 "1123; str.a!1i:s;gs1.*.:1e.- ‘Aim. fire.
`we ms: cmémsnfis. to flu: t3=e.t??‘e*1i<¢.¢:l1
`tsxpaclaiionf “J 15 ‘I }.
`_
`.
`.‘I_ihe:a:e1i_¢s1
`
`Varinkljs
`
`;
`case‘
`betweama ups
`mix-ré:iéaI5g3%tediiL'31iésns'ft?r ztsxezzwof
`-ibupmfeta. admgnismed omiiy
`
`.
`
`is abt9;i:.;ed upon. szswming an
`FF€fliCtI9n.
`epitheiial pemteahiiiiy of fixifri ¢.1v_‘a.
`... ..,__.. . ..... ............ ..,.. . . . . .........
`.................... ».
`- n_ugsu--vu-.a-._.,....... :
`
`
`
`V-"'v||P-a-we-«-3-\.~-:
`
`17!: 3';=.9“.vmw=iM. °*'m?*='5‘”‘=?*-‘*‘ ‘I535-*‘-’*'3" '
`a¢a;;;ed.{gg_ia_i (‘-Eli‘?-‘:'?:§fi‘W33
`Res
`fur GHR?-I
`ioliowing gem!‘
`::
`:
`:::." .
`:
`
`9
`
`J: —.;‘I‘-I**“‘-’??*“°3‘-I--"“"I;‘.7I.—?“E“=
`bdusadwpredzct sheabss
`I
`sy'st§z_i1:=
`r_;__a_;;m.o;_r,= 53$‘ :he{a¢'1¢1i!t.¢3 fmsfi‘-5
`' "':n2a!1;3-li1:hop&:_h_<-‘ 'm‘é§ii:cul®-sg tie
`
`_ at-wt», §'*f.;é§',-isiiaisiesn I:*.S§5.I-
`I
`. Baxsggign. _C._L Hilgera, A.R., Aitéus.
`
`..
`
`I
`
`m§3..
`6. Boiiiéersgu
`;<w9§:».
`
`-
`
`__
`
`Jiaarfiwa £2196‘ "marl Hm-:1! Liesfivé‘
`
`'!sqmr1uu i'3ivifsc’m:s, lie;-mks Imx. S¥)|J.liewni¢:§ RKL, Wilmington, DE .l.98(Ifi_-‘£_59'i
`‘II/KS Cm‘p., 21 !I.1'eI'Mnr5i£m'!}1’..W"s‘si Caiuiwell, NJ M095
`
`§§A1.j:u:z:.-adi-;«s&s'r'.rr; <:£:~sage_:' inrma; tor
`csiticln 3:; 3.53%
`Gc'I\'.'Il? which. aim
`' mm :0 <£e=Jiw.=..=' therapeutic andinr
`._e1ac agents to-me umi mucosa are
`:1 in the an. $ar:vm:.iek€-,=- -and Leun.g__-
`-sc1€b9d F..ri_'Ii.lE2l‘.'¢‘!i3_?.‘ii§SI\r‘-Z3 carzitar
`‘:19 3'1»; cmzrniied ralssase at a
`¢{t13uti£:é3_g€-:9! via aha mucosa
`rising an .:3.-£'.y'dmu_r_=. but hydralahie
`*1T193i‘ rnairn: anti" ammphoas furnad
`"n ogiéinmii wateréinsoéutlte iiian can
`Gd to'g;:u~%ide 21 :'£¢n-sacifié-sing
`2 They: also disclosed
`‘
`a_mina1e
`"tame fur g:>imI_;':=:‘i§§E_3_a. daiivig I'5;f an-
`IE -hgsediam.
`1I‘E8<)!‘8». ca M2:
`5-
`:‘ wily. iuamh -‘chi,-é';"i al. {3}
`-shaped adheisivaa-;3;(:.{¢_3ara*,;§o;;2..
`t'is€s1Q;a:: azfisasiveg ' y':":rr.-mitt‘ "hing;
`waster-‘ss::Es'.I'.>I:'2 am: \i:a1er- insdluhita
`
`'
`
`=:r'.= Sam '
`.
`-siér. thaw deziaiceg mat: ways" we
`'3=r.ri:h a rxsrnsiderabte arm"
`. .
`a from tbs: xvazsa:-i" ' eoiulzie upper:
`
`p.'r.=3aem ir-.-u-er::i<;'r: «'.:=.‘.-I':Iu':t=.‘:':;:3i£:'I~E'ts a
`m whack ta‘.
`[ta zz:'!he:e:‘3_
`t?':'ss.='e§5é ze-Eesssin-3; ":1
`
`phawnaceuficsliy or avosnmiraliy acme
`agent. said iiim carnpnzamg w£r1t3r~e'=cJ§Ubia
`gmiyrreers. :2 comb":naIIo.n-of can-auin
`s:..-rf2:céa.{:se;,.¢ns :3: rmzqe po:’yra::oho!e. and
`ans or mare pharztsaceuticalh or
`ooammicsiry ac‘:.*s.'a ingreulanta. 0$3§0-'IfiIIy.
`1i1a!em1uIa_-.'zon may aoniain calcvranta.
`sweetening agents. Itajvcrrs, iisgvmr
`ermancets. or other excépéents commofliy
`used in
`the mesa rni Earrmiaiimas
`Entersziafi. I-at eppiicafiors It} the era} cavity.
`The .'93«$§.3II.iF:g Iiim is characterized by an
`‘irssfiam -..-ve_t!ab1'1i1y ’,-\fI_15C§’:‘rK'.;EiIJ_3_£E‘c the film-ie
`soélean imstaadiatraiy after; agsxicatinn tome
`mucosa! iissue lhus gtevessaing the patient
`from expargaming ar:y.;_3r’<;&or1ge<:F aflv-Eras
`feeiing. mm mouth.
`'
`‘fire fiim is meanufaciured using
`sew»-ean$=onaJ mating an-:1 <1:-gmg
`51? ink) 939593 0% a shape and size that
`maze: the reqisiremenls eithaspecific -
`appiicamn, and packaged into.su£:ab1_e
`cqntaingrs.
`
`EI(I;:erimenta3
`
`.- zfraa muooazshssivs Eiia-‘r. of the prasedi
`fiwefiiiofl €;OfI':E£ii“-3 55 G5‘-fiefiiial G€.*l'!'|$)<1E'-.£‘¥m$'-
`a wasier-smiuzsls jaaiymar 0: R szamtmaiion of
`wa'te:r-eoé-.:t:1,i:a poiyrfmrs.
`cuirgbinazicnmf
`$£a?fa<:IanE£;: am: or mu£:3.ps§1tai-3choIs. and
`a phannaceutimiiy or cosmetically acisv-3
`mgreafieflt.
`paiymers-arsed-tar the
`tnucoadhesfive film inclnde poeymvgvrs
`are hydrophiiéc as-:5 water-siispevssbie. The
`r._<_:rmir:a:i_c:n as‘ suriacimts used fer :ha
`niucnadhissévsz ream m is nr.=i><tu';Ie. as norticmie
`staxfaciants; The azmaunt
`LSr.w_.; 1:: be
`incmporaiati 1212:: the filmgaeiixgms on
`kind oi.dr:._zg and In u5i._n'-J.i_ly bmabmen 0.3.1
`am: 2%; gwzwi-.
`*Z':r::~sre~.:s1i=-.-.a:i15:.a:-.~.ti-:5: agents
`':IcIL:d5 breath fraahéming r.::rn;1rr::r:¢:2
`{Ike he
`5319! Elaxafs :.w=f:2=M_;ranr:es
`¢c_un:nor:iy;s._ased for ma‘! 'E*:ygis3§x%2. anciior
`= $'£<-a.cL%aia:..2s::’_.=9€-3':
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`RBP_TEVA05024317
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`amives used fen‘ dmtaii m'd.I‘or ural "“'
`cioansing Iike_qiianerri_ary_ ammonium
`bases/%‘her munoadhcssivafiim act:é3'ir'wng"1b
`aha present im(_enfion can be prepared_ as
`Ioilowsf The active ingredient,-surfactants.
`pctyaicomi. -and aossible mus: Iflglfldiéflifi
`ea-zcep1"1h'e wél1I§1'~I'5§!rpef5ifiIe polymer ‘are '=
`dissolved in a snfliciant amt:-uni of asolveni
`' which ES Comiifaltibie
`'Afft'er§§.;fr;Iear_ f-
`-SOIIJIIOTI
`.{ClI_3"_‘I19d'.:thE WHIEFEI
`'
`ciispersible pdlymer or mixture of
`ciispersible pqiymers is_ alcgwty a_t:5der_:I;yr:cl§:_r.
`s:Irring?Imtii' aféiear and hbmogeneopfi
`miutinii has Eiéjen iomiedflzha soI_u1IjaI'\ is:
`coated onto rs suitable‘ carrier malaria! and
`'-
`-clned 1:I~,_»jf<'Jrrn;e'3E§IiIrr1."I'1'¢e Garn‘e_rmai§j1:i;ai
`Z
`must have a éiiiiaoe "l?I'ansciI3r§‘wt1icI1'aliows‘ '
`:he_ poiymer_s;pI_utian :9 be; spread amply _
`acmss_§_th.e intaidded d?a1Ihg width. we
`ccéiingbf Hiéiiébiqfiehfidnib 'tI1s'I
`ma1eriai can be perfarrned using any
`.ca¢wén;icna!-ggpming equipmenl.
`me‘;-gimns ijeieith csess:ea;1ha¢sa1essg§»)we»e§33-
`cu: or punched out ior:the:‘<:I~isiraIeg'rs'itii3n
`and 1iar_:_.siIe strtingih tests; The iansilg
`jstraangfiémf megfiin-ss w}as't$sseSse'd_§;is'§9ig§‘§5-
`..Erir:i19efén {Mafia}! 4743.. M. E;;1_'phse'ir':"'
`GmlJH'.- ifierrnaray) and was" énhresseqgi as."
`I-;-Aha rrsa.ximur=i;.?.nrc&'{N.) (figure; n. A.=2'$*cr.h*
`...‘.l1ii'n waié piaoiééi in ihélneri--dist"; whidhéwasl‘.
`fiiied WIIEI1 deionized water, and lhatime Ior
`--ihe.fiIm=to taigliy disinleyate was reoqrded
`- -;(Figure;2). 'l'he.:des:raase of integsaiian time
`-or iorm'ula1ioéi§'iA t‘-:fE=wa§='accbmp'éi‘iied by
`.madec;raas9
`terisiie furceasfihe.... ..
`..
`--fiarmulatiuns.
`5 cijireialion-ihdicaigd ihai
`I-fjlhe cliéiéé oI__t_he mos!
`Iurrri'uI_.a1io'ri
`coma be -by either-the tensile
`- ustreng-t;'I or the-disinte_z_gra1i_or: test. -
`.-
`
`-
`
`Q.
`
`-55.
`fizzkisse in=§_ha.<_>g-a
`j"
`'
`SWBIE -sd£ut§i'e."
`
`
`.__;casrier§.v:xarrw[_ '
`-555mmbiriéaiibh:;51-$3131"-cé?tain-'in§g#édiet}i$;-fififi 5 "
`'
`prewdiasa =a-.fherapse¢:iié=a:1d?dr;aosmeIin'- -
`- e§fect.:f{he-fififffis aoagggd afndi¢::si_eci;Lj;Ii' Eng
`existing oaanpg1acm1pwgy_.ar-d
`.3.-2.
`-1.: Insisniiiwsflaliility ro'm'med=tay -rapid "
`
`-
`
`'
`
`fita:-£31221-.EH.‘I-.3;-_§g;£er§§_mi,8_
`':>2nI§*a'11ed 32313
`
`I"
`
`"I dissatiéiiianfdiéirilegratioriiupon
`administration in the oral cavity.
`
`Flelerencas
`
`D.FI. arid LI3ung,.S~H.
`-- {1}
`--
`US paietit 5'.B4'3'.244. 1991.
`{2} Sanvordeker, DR. and Lanug. 3-H. 5
`W0 patent El‘UOB270,: 1991.
`'
`E3! MIz'obuc_hi'.'T., Unit, 'A':,3Sakoh.5 S."-an
`Mugurflma, Y.‘ US Palefit 4,878,092. ‘I
`{4} Kuroya. T, and Enoueg. Y. European
`Patent-G-381496-81,— 1995.
`‘7
`-
`(53 Biarik. H=.G'., Mody. D;'S.. Kenn}!-, FLJ
`and mason". MO. US Patent 4,946,584,
`1990‘
`'
`.
`..
`(63 tncue, T;‘.'Maada,'K."a'md Eguchi.‘ Y.
`Patent §,2G8.'D10. 1993. -
`'
`
`9'
`..;._j§;
`5 5
`Fonmilaxéons "
`
`'=
`
`F 5303
`
`“Inter Soluble fiilytaiiom fer Cnntrollcd Definer}! Systems
`
`Nanditfi lions! midclmng-.ja Kim-
`
`St:hooiofPhannacy, Tempie Unilflersity, Philadelphh, PA 19140
`irifliis study, ws.p:esem the zero-order.
`reiéase kinsaflcs of was: soluble anionic drugs fham
`emdible,
`3-a.b1e¢s)_usmg
`P91)!IYri:riefl1y1an:inoeflI)d' rnaimcfylaxae daldride _-co-.
`(PTMAEMCIMMA):
`
`_ _hiiD‘:Iy cross-linkad p-oIy{s:3'rene:'di\-inyi
`qnaiernizefi) or c:os.s.~linked
`
`-
`
`.
`
`'
`3
`I
`"{CH:' 1‘-rm:
`(rm
`
`I
`
`'
`
`5 _
`-16
`<cs+=i.1.~r(craL-at
`Cl‘
`
`.
`.
`.
`.
`Eatjaerimeiam MerhudI:
`:5-)*nh\'¢.w'3 c.fPT'M‘.»!£MC/‘.1-ill;-f dadflrqaaration 9}‘
`Bug Rtabuarg J'a-flan”
`PTMAEMCIMMA was "Wm -by the-
`Bae-1ad.ira_1 sciution poiymerization of‘IP'I'MA£MC
`$4995} 3113 MMA (59%) as repda‘ted earlier [7]. The
`polfilmer was tlissnlwii fin
`mm,
`a
`“.3 WWW 19 flit? Iifiirmr 1115
`compleiws Iireo'i;IilauxI_;i:z watuwere recovered and
`times
`-dried
`élzyg-msinatfiwexu cmshed in amdnariamipesflem
`I?9Y~7d9-'3-
`:TaI*1E¥9
`-.-W1
`‘hbl:ica‘I‘.g_I‘.Hn 9.0 inmg
`die and
`afigstsmffieepunzhwigli acarvarpressi
`Drug Rdmwfmefim Tests
`'
`' "
`._
`The drug 're:£m5sa kiriaizcs
`tabkéts
`camad m¢'3m'ooI -M‘pho§p'hme
`cdaitamisig amm animmts of NaC£ at 31°C bfthe
`I-I5? basket ‘mefliud up 100 rpm, m1.Izess_
`nouasi Ding reiaase was nzaraitmed on -a HPMSEA
`divode-ariajr_'spectmpI1oIcmeser aot,2.S0nm and 290mm
`firr diclofeuac Na and sulfaahiénwla Na as made!
`drugs, taspectimy-.
`-
`'
`'
`
`mm""3 the-rimii: :pemlant'
`&flJsd$fia:eax1'cmssrlinJ;i.n_goffi1epolyrner
`I
`degree offiswellilig of
`-charged
`
`T was Ilmfieasible fumes; _i'onic gels tqhe
`mI*Ii§Iiw=3' menu.
`-the""pH
`Zdima-w'_=fi92a
`aims;-I1-e
`-- :1! {GI} ma;'=Nu3wm'.and Kim "[5]
`
`o-lfigriwer tI1an§'-£0
`WIIIDII h'99..j.§..:j.d11-lg
`_II!tains aet'o'-omen’ roléasekirietics for a Itmg
`-rim» be:-:,_ausie the ‘drug magma mauiggg '3
`that
`side dufiri until-Itlle
`is
`by‘
`It was fiiimd
`Thee€£actofi1ni1ic:I;retagthondiclc£Fes:aq1'\Ia
`I‘
`'°1°3"i°._‘.1.‘5$.9 5'1d°P_°*}5W-.°.§¢I*9 P3 Gfibfi
`' m?edi:an'i"as long as"'I.he iaiiic strerigth was
`am;-1'*'rMAEMc:MM'.s.
`cam"‘pm
`neléése
`'
`0.1 Mwhidxkcmfimmhubswvadm the
`is shown in Figure 1. Tablas of
`eauigzs at:1_:I'i'a‘
`200mg u.-sigh were foérmulaied _witb: 20 % deiéfrose
`5]-' ‘ID
`wh.i;t;'§ are-an cumzmsx
`as;-a tabla! bindm. 1'53 bI.1fl%1':om?sin.atI 30! M
`ieieasaiigfiésaaxz form
`sueoessflsiiy
`fimnflsesié
`'
`phowate and "II-4's(3I rangissg {from 0.05 M an 0.2 M
`I‘r9¢.ee~=).i:-.‘.-.I:‘1.5§I9.£o=Im3.&e1.seea::.aiz:ar.,'1s§:;9'i;
`-
`9'<lj.;'tg‘;i=_$5;= §u.r::ét'y.
`In-:.
`:
`'
`:
`
`__.£_2g_
`
`RBP_TEVA05024318
`
`TEVA EXHIBIT 1022
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC